Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Gulbenkian Institute For Molecular Medicine

Clinical trials sponsored by Gulbenkian Institute For Molecular Medicine, explained in plain language.

Trials to join now! 2
Sort by
  • Gut bacteria may hold key to early colorectal cancer detection

    Diagnosis Recruiting now

    This study is looking for 400 adults in Portugal, aged 40 to 74, who have recently been diagnosed with colorectal cancer but haven't started treatment yet. Researchers want to see if analyzing the bacteria in a person's stool can help detect cancer earlier and predict outcomes. T…

    Sponsor: Gulbenkian Institute for Molecular Medicine • Aim: Diagnosis

    Last updated May 22, 2026 14:04 UTC

  • Gut microbiome study aims to revolutionize colorectal cancer detection

    Knowledge-focused Recruiting now

    This study looks at bacteria in stool samples from 30,000 people aged 40-74 in Portugal to find new markers for early colorectal cancer detection. Researchers will compare gut microbiome patterns with standard screening tests and colonoscopy results. The goal is to develop a more…

    Sponsor: Gulbenkian Institute for Molecular Medicine • Aim: Knowledge-focused

    Last updated May 22, 2026 13:54 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space